Torrent Pharmaceuticals Ltd.
TORNTPHARM
3314.2
0.00 (-0.75%)Torrent Pharmaceuticals has established itself as a major player in the Indian Pharma arena. The company has well segregated marketing divisions, strategically structured on specific therapeutic areas and enjoys dominance in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). With Unichem's domestic business acquisition, Torrent has entered the list of top pharma firms in the Indian Pharma Market (IPM) and is ranked No 8 in the IPM.
Shareholding Pattern
| On | Ind. Pro. | Fore. Pro. | FII/FPI | Mutual Funds | Banks | Insurance | Others | Non/Institution |
|---|---|---|---|---|---|---|---|---|
| 2024-09 | 71.25 | 0 | 14.46 | 3.69 | 0 | 1.89 | 1.50 | 7.21 |
| 2024-06 | 71.25 | 0 | 14.22 | 4.35 | 0.01 | 2 | 0.91 | 7.26 |
| 2024-03 | 71.25 | 0 | 14.14 | 4.46 | 0 | 1.95 | 0.85 | 7.36 |
| 2023-12 | 71.25 | 0 | 14.08 | 4.48 | 0 | 1.96 | 0.78 | 7.45 |
| 2023-09 | 71.25 | 0 | 13.15 | 5.32 | 0 | 1.85 | 0.84 | 7.6 |
| 2023-06 | 71.25 | 0 | 12.85 | 5.59 | 0 | 1.99 | 0.73 | 7.6 |
| 2023-03 | 71.25 | 0 | 12.04 | 6.37 | 0 | 1.87 | 0.76 | 7.71 |
| 2022-12 | 71.25 | 0 | 12.09 | 6.23 | 0 | 1.99 | 0.65 | 7.8 |
| 2022-09 | 71.25 | 0 | 11.37 | 6.72 | 0 | 2.16 | 0.62 | 7.88 |
Results
| On | Income from Inv. | Int. on Bank Bal. | Int. on Advances | Other Int. | Interest Earned | Interest Exp. | Net Interest Income | Expenditure | Operating Income | Other Income | Prov. & Contingencies | PBT | Tax | PAT | Net Profit | Consolidated Net Profit | Adjusted EPS(Rs.) | Gross NPA | Gross NPA(%) | Net NPA | Net NPA(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09 | 0 | 0 | 0 | 0 | 2889 | 64 | 2825 | 1950 | 923 | -16 | 0 | 661 | 208 | 453 | 453 | 453 | 13.38 | 0 | 0% | 0 | 0% |
| 2024-06 | 0 | 0 | 0 | 0 | 2859 | 75 | 2784 | 1955 | 928 | 24 | 0 | 656 | 199 | 457 | 457 | 457 | 13.50 | 0 | 0% | 0 | 0% |
| 2024-03 | 0 | 0 | 0 | 0 | 2745 | 80 | 2665 | 1862 | 914 | 31 | 0 | 631 | 182 | 449 | 449 | 449 | 13.27 | 0 | 0% | 0 | 0% |
| 2023-12 | 0 | 0 | 0 | 0 | 2732 | 80 | 2652 | 1863 | 836 | -33 | 0 | 631 | 188 | 443 | 443 | 443 | 13.09 | 0 | 0% | 0 | 0% |
| 2023-09 | 0 | 0 | 0 | 0 | 2660 | 91 | 2569 | 1835 | 851 | 26 | 0 | 559 | 173 | 386 | 386 | 386 | 11.40 | 0 | 0% | 0 | 0% |
| 2023-06 | 0 | 0 | 0 | 0 | 2591 | 103 | 2488 | 1800 | 825 | 34 | 0 | 531 | 153 | 378 | 378 | 378 | 11.17 | 0 | 0% | 0 | 0% |
| 2023-03 | 0 | 0 | 0 | 0 | 2491 | 107 | 2384 | 1764 | 736 | 9 | 0 | 433 | 146 | 287 | 287 | 287 | 8.48 | 0 | 0% | 0 | 0% |
| 2022-12 | 0 | 0 | 0 | 0 | 2491 | 102 | 2389 | 1767 | 714 | -10 | 0 | 419 | 127 | 292 | 292 | 292 | 8.63 | 0 | 0% | 0 | 0% |
| 2022-09 | 0 | 0 | 0 | 0 | 2291 | 69 | 2222 | 1612 | 695 | 16 | 0 | 463 | 151 | 312 | 312 | 312 | 9.22 | 0 | 0% | 0 | 0% |
| 2022-06 | 0 | 0 | 0 | 0 | 2347 | 55 | 2292 | 1635 | 742 | 30 | 0 | 532 | 178 | 354 | 354 | 354 | 10.46 | 0 | 0% | 0 | 0% |